I'ROM GROUP CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,273 JPY | +21.36% |
|
+23.87% | +13.14% |
| 2023 | I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2022 | Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 1,890.00 | 2,083.00 | 2,056.00 |
| Spread/Res. | +20.26% | +9.12% | +10.55% |
| Spread/Supp. | +25.23% | +30.86% | +36.76% |
| Support | 1,815.00 | 1,737.00 | 1,662.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 2372 Stock
- Charts I'rom Group Co., Ltd.